Cysticercosis: Recent advances in diagnosis and management of neurocysticercosis

Current Infectious Disease Reports

Volumn 7, Issue 1, 2005, Pages 39-47

  Yancey, Linda S ^b   Diaz Marchan, Pedro J ^b   White, Arthur Clinton ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALBENDAZOLE; ANTICONVULSIVE AGENT; ANTIPARASITIC AGENT; CASTOR OIL; CORTICOSTEROID; DIURETIC AGENT; LAXATIVE; MACROGOL DERIVATIVE; MANNITOL; PREDNISOLONE; PYRUVIC ACID; RECOMBINANT VACCINE; STEROID; SUCCINIC ACID;

ANIMAL PARASITOSIS; ARTERIOVENOUS SHUNT; ARTICLE; BLOOD ANALYSIS; BRAIN EDEMA; BRAIN VENTRICLE TUMOR; BRAIN VENTRICULITIS; CALCIFICATION; CEREBROSPINAL FLUID SHUNTING; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTICERCUS; DRUG MEGADOSE; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; FOOD CONTAMINATION; HEADACHE; HISTOLOGY; HOST PARASITE INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; IMMUNE SYSTEM; INFECTION CONTROL; INFLAMMATION; MEAT INDUSTRY; MENINGITIS; NEUROCYSTICERCOSIS; NEUROIMAGING; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; PARASITE SERODIAGNOSIS; PARENCHYMA; PATHOGENESIS; PROTON NUCLEAR MAGNETIC RESONANCE; RISK BENEFIT ANALYSIS; RISK FACTOR; SEIZURE; SERODIAGNOSIS; SWINE; TAENIA SOLIUM; TAENIASIS; TREATMENT CONTRAINDICATION;

EID: 13544254607     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-005-0022-0     Document Type: Article

References (50)

1. White AC Jr: Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Ann Rev Med 2000, 51:187-206.
2. Garcia HH, Gonzalez AE, Evans CA, et al.: Thenia solium cysticercosis. Lancet 2003, 362:547-556.
3. Zoli A, Shey-Njila O, Assana E et al.: Regional status, epidemiology and impact of Taenia solium cysticercosis in Western and Central Africa. Acta Trop 2003, 87:35-42.
4. Phiri IK, Ngowi H, Afonso S, et al.: The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk. Acta Trop 2003, 87:13-23.
5. Hira PR, Francis I, Abdella NA, et al.: Cysticercosis: imported and autochthonous infection in Kuwait. Trans R Soc Trop Med Hyg 2004, 98:233-239.
6. Townes JM, Hoffmann CJ, Kohn MA: Neurocysticercosis in Oregon, 1995-2000. Emerg Infect Dis 2004, 10:508-510.
7. Ong S, Talan DA, Moran GJ, et al.: Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 2002, 8:608-613.
8. Del Brutto OH, Wadia NH, Dumas M, et al.: Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci 1996, 142:1-6.
9. Del Brutto OH, Rajshekhar V, White AC Jr, et al.: Proposed diagnostic criteria for neurocysticercosis. Neurology 2001, 57:177-183.
10. Garg RK: Diagnostic criteria for neurocysticercosis: some modifications are needed for Indian patients. Neurol India 2004, 52:171-177.
11. Jeri C, Gilman RH, Lescano AG, et al.: Species identification after treatment for human taeniasis. Lancet 2004, 363:949-950.
12. Gonzalez LM, Montero E, Morakote N, et al.: Differential diagnosis of Taenia saginata and Taenia saginata asiatica taeniasis through PCR. Diagn Microbiol Infect Dis 2004, 49: 83-188.
13. Yamasaki H, Allan JC, Sato MO, et al.: DNA differential diagnosis of taeniasis and cysticercosis by multiplex PCR. J Clin Microbiol 2004, 42:548-553.
14. Wilkins PP, Allan JC, Verastegui M, et al.: Development of a serologic assay to detect Taenia solium taeniasis. Am J Trop Med Hyg 1999, 60:199-204.
15. Levine MZ, Calderon JC, Wilkins PP, et al.: Characterization, cloning, and expression of two diagnostic antigens for Taenia solium tapeworm infection. J Parasitol 2004, 90: 31-638.
16. Hancock K, Pattabhi S, Greene RM, et al.: Characterization and cloning of GP50, a Taenia solium antigen diagnostic for cysticercosis. Mol Biochem Parasitol 2004, 133: 15-124.
17. Kojic EM, White AC Jr: A positive enzyme-linked immuno-electrotransfer blot assay result for a patient without evidence of cysticercosis. Clin Infect Dis 2003, 36:e7-e9.
18. Hancock K, Khan A, Williams FB, et al.: Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis. J Clin Microbiol 2003, 41:2577-2586.
19. Fleury A, Hernandez M, Fragoso G, et al.: Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis. Trans R Soc Trop Med Hyg 2003, 97:542-546.
20. Mishra AM, Gupta RK, Jaggi RS, et al.: Role of diffusion-weighted imaging and in vitro proton magnetic resonance spectroscopy in the differential diagnosis of ring-enhancing intracranial cystic mass lesions. J Comput Assist Tomogr 2004, 28: 40-547.
21. Braga F, Rocha AJ, Gomes HR, et al.: Noninvasive MR cisternography with fluid-attenuated inversion recovery and 100% supplemental O(2) in the evaluation of neurocysticercosis. Am J Neuroradiol 2004, 25:295-297.
22. Agarwal M, Chawla S, Husain N, et al.: Higher succinate than acetate levels differentiate cerebral degenerating cysticerci from anaerobic abscesses on in vivo proton MR spectroscopy. Neuroradiology 2004, 46:211-215.
23. Jayakumar PN, Srikanth SG, Chandrashekar HS, et al.: Pyruvate: an in vivo marker of cestodal infestation of the human brain on proton MR spectroscopy. J Magn Reson Imaging 2003, 18: 75-680.
24. Chawla S, Gupta RK, Husain N, et al.: Prediction of viability of porcine neurocysticercosis with proton magnetic resonance spectroscopy: correlation with histopathology. Life Sci 2004, 74:1081-1092.
25. Garcia HH, Evans CA, Nash TE, et al.: Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002, 15:747-756.
26. Carpio A, Hauser WA: Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002, 59:1730-1734.
27. Garcia HH, Pretell EJ, Gilman RH, et al.: A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004, 350:249-258.
28. Singh G, Kaushal S, Gupta M, Chander Chopra S: Cutaneous reactions in patients with solitary cysticercus granuloma on phenytoin sodium. J Neurol Neurosurg Psychiatry 2004, 75:331-333.
29. Stringer JL, Marks LM, White AC Jr, Robinson P: Epileptogenic activity of granulomas associated with murine cysticercosis. Exp Neurol 2003, 183:532-536.
30. Rajshekhar V, Chandy MJ: Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures. Acta Neurol Scand 1997, 96:76-81.
31. Singhi P, Ray M, Singhi S, Khandelwal N: Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Child Neurol 2000, 15:207-213.
32. Singhi P, Jain V, Khandelwal N: Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis. J Child Neurol 2004, 19:323-327.
33. Mall RK, Agarwal A, Garg RK, et al.: Short course of prednisolone in Indian patients with solitary cysticercus granuloma and new-onset seizures. Epilepsia 2003, 44:1397-1401.
34. Garg RK, Kar AM, Singh MK: Prednisolone-responsive headache in patients with solitary cysticercus granuloma and seizures. Headache 2004, 44:365-369.
35. Salinas R, Prasad K: Drugs for treating neurocysticercosis (tapeworm infection of the brain). Cochrane Database Syst Rev 2000, CD000215.
36. Nash TE, Del Brutto OH, Butman JA, et al.: Calcific neurocysticercosis and epileptogenesis. Neurology 2004, 62: 934-1938.
37. Garcia-Noval J, Moreno E, de Mata F, et al.: An epidemiological study of epilepsy and epileptic seizures in two rural Guatemalan communities. Ann Trop Med Parasitol 2001, 95: 67-175.
38. Gupta RK, Kumar P, Chawla S, Pradhan S: Demonstration of scolex within calcified cysticercus cyst: its possible role in the pathogenesis of perilesional edema. Epilepsia 2002, 43: 502-1508.
39. Wichert-Ana L, Velasco TR, Terra-Bustamante VC, et al.: Surgical treatment for mesial temporal lobe epilepsy in the presence of massive calcified neurocysticercosis. Arch Neurol 2004, 61:1117-1119.
40. Torabi AM, Quiceno M, Mendelsohn DB, Powell CM: Multilevel intramedullary spinal neurocysticercosis with eosinophilic meningitis. Arch Neurol 2004, 61:770-772.
41. Psarros TG, Krumerman J, Coimbra C: Endoscopic management of supratentorial ventricular neurocysticercosis: case series and review of the literature. Minim Invasive Neurosurg 2003, 46: 31-334.
42. Bergsneider M, Holly LT, Lee JH, et al.: Endoscopic management of cysticercal cysts within the lateral and third ventricles. J Neurosurg 2000, 92:14-23.
43. Bergsneider M, Nieto JH: Endoscopic management of intraventricular cysticercosis. In Taenia solium Cysticercosis: From Basic to Clinical Science. Edited by Singh G and Prabhakar S. Oxford: CABI Publishing; 2002:399-410.
44. Proano JV, Madrazo I, Avelar F, et al.: Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 2001, 345:879-885.
45. Marquez-Caraveo C, Gongora-Rivera F, Santos Zambrano J, et al.: Pre-treatment with corticosteroids and a single cycle of high dose albendazole for subarachnoidal cysticercosis. J Neurol Neurosurg Psychiatry 2004, 75:938-939.
46. Delobel P, Signate A, El Guedj M, et al.: Unusual form of neurocysticercosis associated with HIV infection. Eur J Neurol 2004, 11:55-58.
47. Gonzalez AE, Garcia HH, Gilman RH, et al.: Control of Taenia solium. Acta Trop 2003, 87:103-109.
48. Lightowlers MW, Colebrook AL, Gauci CG, et al.: Vaccination against cestode parasites: anti-helminth vaccines that work and why. Vet Parasitol 2003, 115:83-123.
49. Flisser A, Gauci CG, Zoli A, et al.: Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect Immun 2004, 72:5292-5297.
50. Guo YJ, Sun SH, Zhang Y, et al.: Protection of pigs against Taenia solium cysticercosis using recombinant antigen or in combination with DNA vaccine. Vaccine 2004, 22:3841-3847.